ISSX/JSSX, DMDG & ICNPR
AIM Research catching up with current clients and meeting new scientists at DMDG 2024 and ICNPR 2024.
Exciting Summer Ahead!
Fantastic summer conferences ahead!
Merry Christmas & Happy New Year
AIM Research Co. fulfilling end-of-year POs and preparing for European demos in January. Wishing you the best in 2024.
Event: Applied Pharmaceutical Analysis 2023
AIM Research Co. sponsors APA 2023 hosted at Merck Research Laboratories
Janssen publishes Novel Drug Study using v.ARC 3
Johnson & Johnson Innovative Medicines (formerly Janssen) DMPK group publishes metabolism study for novel NSAID drug utilizing the high performance v.ARC 3 radioisotope detector for metabolite identification
Event: 25th North American ISSX
AIM Research Company at 25th North American ISSX Meeting 2023 in Boston
Q2 Solutions Lab Tour ft. LCJet Fraction Collector
LCJet high capacity fast fraction collector featured in the 24,000 sq. ft. ADME Laboratory
Janssen Scientists Pioneer New Quantitation Method for Metabolites in Plasma
New standard-free quantitation methodology developed featuring v.ARC Model 3 radioisotope detector
Celerion Virtual Lab Tour ft. LCJet & v.ARC 3 with DOT
LCJet Model C and v.ARC Model 3 with DOT featured in Celerion Met ID lab tour
New Publication by Biogen Team
v.ARC Model 2 online radioisotope detector featured in 2023 Xenobiotica publication.
Upcoming Event: ISSX North American 2023
AIM Research Co. at European ISSX/DMDG 2023 and plans for North American ISSX Sept 10-13 2023
